A PROSPECTIVE ANALYSIS OF ADVERSE DRUG REACTIONS IN PSYCHIATRIC PATIENTS

dc.contributor.guideDr. M. RAMESH
dc.coverage.spatialPHARMACY
dc.creator.researcherLUCCA JISHA M.
dc.date.accessioned2016-03-03T08:50:22Z
dc.date.available2016-03-03T08:50:22Z
dc.date.awarded
dc.date.completed
dc.date.registered
dc.description.abstractThe overall incidence of ADRs in patient with mental disorders was 37.6%. The system organ class most commonly affected was gastrointestinal system [n=225 (22.7%)] while dry mouth (n=101) and weight gain (n=81) were the commonly reported ADRs. Antidepressants [n=415 (42%)] and antipsychotics [n=405 (41%)] were the class of drugs frequently implicated in ADRs, whereas escitalopram [15.9% (n=158)] and olanzapine [12.1% (n=120)] were the most commonly implicated individual medications. About one half (51.6%) of the ADRs were probable in their causal relationship and 76.6% of the ADRs were mild in their severity, while majority (94.6%) of ADRs were non serious in nature. In 76.7% (n=760) of the cases, ADRs were predictable and 81.2% (n=804) of ADRs were not preventable . Female gender (p=0.002), patients presented with co morbid conditions (p=0.001) and drug- drug interactions (p=0.000) were the predictors of both short-term and long-term ADRs. The incidence of ADI with respect to the total number of patients with DDIs was 12%. Pharmacodynamic interactions accounted for the majority [n=98 (68.5%)] of ADIs. Approximately one-half of the ADIs were caused by moderate DDIs. Majority (64.7%) of ADIs were probable in their causal relationship. Patients receiving gt5 drugs were found to have six times higher risk of developing ADIs than the patients receiving lt5 drugs [OR 7.024 95% CI; 2.745-17.976; p=000]. The total and average direct cost associated with the management of ADRs was INR 114731.00/- and INR 482/- respectively. newlineThis prospective surveillance study provides a representative data of safety profile of the psychotropic agents likely to be encountered in Indian psychiatric patients.ADRs and ADIs are important cause of increased burden of disease and unnecessary healthcare expenditure. Constant vigil in early detection and reporting of ADRs and subsequent management can make the therapy with psychotropic agents safer and effective and decreases cost. Clinical pharmacist can play a vital role in the detec
dc.description.noteREFERENCE 34
dc.format.accompanyingmaterialDVD
dc.format.dimensions
dc.format.extenti-iv p17
dc.identifier.urihttp://hdl.handle.net/10603/73723
dc.languageEnglish
dc.publisher.institutionColleges of Pharmacy
dc.publisher.placeMysore
dc.publisher.universityJSS University
dc.relation281
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordAdverse Drug Reactions, Adverse Drug Interaction, Cost, Drug-Drug Interactions, Mental Health, Psychiatric Patients, Predictors, Pharmacovigilance.
dc.titleA PROSPECTIVE ANALYSIS OF ADVERSE DRUG REACTIONS IN PSYCHIATRIC PATIENTS
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 12
Loading...
Thumbnail Image
Name:
01.title page.pdf
Size:
167.25 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02.certificate.pdf
Size:
1.86 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03.acknowledgement.pdf
Size:
29.63 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04.list of abrevations.pdf
Size:
47.09 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05.content page.pdf
Size:
33.57 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: